– As an operating model, the virtual company has been effective. For instance, there have been no breaks in communication in outsourced product development, says Lasse Leino, Managing Director of the company.
In the virtual company, most of the resource-intensive R&D has been outsourced, and research has been almost completely outsourced to service companies and research institutes in the field of pharmaceuticals. BioCis Pharma Ltd has demonstrated that new drugs can be developed without millions of euros of investment, if product development is well-planned right from the start, and cost-effectiveness is built into company strategy. Support from the incubator has also been important to the company.
– We were immediately able to direct money at product development, which was of great benefit to us. The laboratory facilities provided by the Biotech Incubator at Turku Science Park Ltd were one of the most concrete and important forms of support, says Leino gratefully.
